Leonid Timashev
Stock Analyst at RBC Capital
(0)
# 4044
Out of 5,240 analysts
62
Total ratings
29.82%
Success rate
-5.24%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Compass Pathways | Reiterates: Outperform | 18 18 | 3.45 | 421.74% | 4 | Jan 15, 2025 | |
Pyxis Oncology | Reiterates: Outperform | 10 8 | 1.41 | 467.38% | 5 | Dec 20, 2024 | |
Cytokinetics | Maintains: Outperform | 80 82 | 47.28 | 73.43% | 2 | Dec 18, 2024 | |
Legend Biotech | Reiterates: Outperform | 86 86 | 31.6 | 172.15% | 12 | Dec 9, 2024 | |
Biohaven | Reiterates: Outperform | 58 61 | 36.74 | 66.03% | 9 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 130 131 | 87.6 | 49.54% | 7 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 42 | 28.89 | 45.38% | 9 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 31 31 | 24.29 | 27.62% | 5 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 4.1 | -2.44% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |